Cover Image
市場調查報告書

泌尿道感染:全球臨床實驗檢討

Urinary Tract Infections Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 322158
出版日期 內容資訊 英文 81 Pages
訂單完成後即時交付
價格
Back to Top
泌尿道感染:全球臨床實驗檢討 Urinary Tract Infections Global Clinical Trials Review, H2, 2014
出版日期: 2014年12月31日 內容資訊: 英文 81 Pages
簡介

本報告提供泌尿道感染的臨床實驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 泌尿道感染
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要5個國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病臨床實驗上泌尿道感染所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病臨床實驗上泌尿道感染所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

泌尿道感染治療藥臨床實驗的主要參與企業

有潛力的藥劑

泌尿道感染相關的最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Merck & Co., Inc.
    • Zambon Company S.p.A.
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • AstraZeneca PLC
    • Astellas Pharma Inc.
    • Janssen Pharmaceuticals, Inc.
    • 第一三共
    • Tetraphase Pharmaceuticals Inc.
    • Actavis plc
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Center for Complementary and Alternative Medicine
    • U.S. Department of Veterans Affairs
    • Assistance Publique - Hopitaux de Paris
    • Lawson Health Research Institute
    • University of Washington
    • Medical University of Vienna
    • Samsung Medical Center
    • University of Pittsburgh
    • Leiden University Medical Center
    • University of Missouri

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2499CTIDB

GlobalData's clinical trial report, "Urinary Tract Infections Global Clinical Trials Review, H2, 2014" provides data on the Urinary Tract Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Urinary Tract Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Urinary Tract Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Urinary Tract Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Urinary Tract Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Urinary Tract Infections Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Urinary Tract Infections
    • Oct 06, 2014: Tetraphase Pharmaceuticals Announces Initiation of Pivotal Portion of IGNITE 2 Phase 3 Trial of Eravacycline in cUTI
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Zambon Company S.p.A.
      • Clinical Trial Overview of Zambon Company S.p.A.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Janssen Pharmaceuticals, Inc.
      • Clinical Trial Overview of Janssen Pharmaceuticals, Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Tetraphase Pharmaceuticals Inc.
      • Clinical Trial Overview of Tetraphase Pharmaceuticals Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
    • Clinical Trial Overview of Top Institutes / Government
      • National Center for Complementary and Alternative Medicine
      • Clinical Trial Overview of National Center for Complementary and Alternative Medicine
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Lawson Health Research Institute
      • Clinical Trial Overview of Lawson Health Research Institute
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • University of Missouri
      • Clinical Trial Overview of University of Missouri
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Region, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Urinary Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Urinary Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Urinary Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Urinary Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Urinary Tract Infections Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Urinary Tract Infections Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Urinary Tract Infections Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Urinary Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Tetraphase Pharmaceuticals Inc., 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2014*

List of Figures

  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Urinary Tract Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Urinary Tract Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Urinary Tract Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Urinary Tract Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Urinary Tract Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Urinary Tract Infections Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Urinary Tract Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Urinary Tract Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top